Recently Rated:
Stats
Location:
Work interests:
Affiliation/website:
Preferred contact method: Reply to post in blog/forum/group
Preferred contact language(s):
Contact:
Favourite publications:
Work interests:
Affiliation/website:
Preferred contact method: Reply to post in blog/forum/group
Preferred contact language(s):
Contact:
Favourite publications:
Founding Member
Location: Lagos, Nigeria
Work: HIV/AIDS; Medicines Access; Policy & Advocacy
Biographical: OLATUBOSUN OBILEYE, MPS, MCPA 45, Modupe Street, Off Fola Agoro, Akoka, Lagos, Nigeria. Tel: +234 8060455577 olatubosunobileye@yahoo.co.uk CONTRACT/CONSULTANCY Research Assistant TRIALS & TRIBULATION OF TENOFOVIR: ETHICS, POLITICAL 2008 ECONOMIC AND CLINICAL RESEARCH IN AFRICA UNIVERSITY OF CALIFORNIA Intramural Research Grant Program Award, Michigan State University 2006 Sustaining AIDS prevention and treatment: The US President’s Emergency Program for AIDS Relief (PEPFAR) in Nigeria National Agency for Control of HIV/AIDS (NACA): Nigeria HIV/AIDS Summit: 2006 Beyond Boundaries – Strengthening the National Response, Abuja. Rapporteur; Editing & Communiqué Medecins sans Frontieres French Section 2005 Pharmacist / Medicines & Commodity Logistician Health System Management Consultants Limited. Consultant/Policy analyst, Advisory services • Prototype Proposal for the Social Marketing of Hypoglycemic products for Nigerian German Chemical Company (2006) • National Action Committee on AIDS (2005): State Facility Services & Infrastructure Baseline Data Collection for Anti- retroviral Therapy. • Abstract Reviewer, ICASA 2005: HIV/AIDS & the Family – review of scientific & NGO/Community abstracts on Treatment, Care & Support submitted for presentation at the 14th International conference on HIV/AIDS & Sexually transmitted Infections in Africa (ICASA), Abuja, Nigeria. • Resource Person, World Health Organization (2005) – Expert committee on Drug Distribution Guideline for Nigeria. • Resource person/Workshop facilitator, ENHANCE/NAFDAC (2005): National Workshop on Regulation of ARV/OI Drugs & Related Biological Products • Resource person, NHVMAG/Global Campaign for Microbicide (2005) – I.P.R and New prevention technologies: the role of the Ethics Review Board. • Resource person, The Nigeria HIV Vaccine and Microbicide Advocacy Group's (2005) - Phase 2 trial of Oral Tenofovir use as a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process. The Policy Projects, The Futures Group International 2001- 2002 Consultancy Co-authored a policy paper titled Access to Drugs for HIV/AIDS and Related Opportunistic Infections in Nigeria. Medecins sans Frontieres Holland (Doctors without Borders) 2000- 2002 Coalition of Civil Society Groups on Access to Essential Medicines 2000-2002 P
Work: HIV/AIDS; Medicines Access; Policy & Advocacy
Biographical: OLATUBOSUN OBILEYE, MPS, MCPA 45, Modupe Street, Off Fola Agoro, Akoka, Lagos, Nigeria. Tel: +234 8060455577 olatubosunobileye@yahoo.co.uk CONTRACT/CONSULTANCY Research Assistant TRIALS & TRIBULATION OF TENOFOVIR: ETHICS, POLITICAL 2008 ECONOMIC AND CLINICAL RESEARCH IN AFRICA UNIVERSITY OF CALIFORNIA Intramural Research Grant Program Award, Michigan State University 2006 Sustaining AIDS prevention and treatment: The US President’s Emergency Program for AIDS Relief (PEPFAR) in Nigeria National Agency for Control of HIV/AIDS (NACA): Nigeria HIV/AIDS Summit: 2006 Beyond Boundaries – Strengthening the National Response, Abuja. Rapporteur; Editing & Communiqué Medecins sans Frontieres French Section 2005 Pharmacist / Medicines & Commodity Logistician Health System Management Consultants Limited. Consultant/Policy analyst, Advisory services • Prototype Proposal for the Social Marketing of Hypoglycemic products for Nigerian German Chemical Company (2006) • National Action Committee on AIDS (2005): State Facility Services & Infrastructure Baseline Data Collection for Anti- retroviral Therapy. • Abstract Reviewer, ICASA 2005: HIV/AIDS & the Family – review of scientific & NGO/Community abstracts on Treatment, Care & Support submitted for presentation at the 14th International conference on HIV/AIDS & Sexually transmitted Infections in Africa (ICASA), Abuja, Nigeria. • Resource Person, World Health Organization (2005) – Expert committee on Drug Distribution Guideline for Nigeria. • Resource person/Workshop facilitator, ENHANCE/NAFDAC (2005): National Workshop on Regulation of ARV/OI Drugs & Related Biological Products • Resource person, NHVMAG/Global Campaign for Microbicide (2005) – I.P.R and New prevention technologies: the role of the Ethics Review Board. • Resource person, The Nigeria HIV Vaccine and Microbicide Advocacy Group's (2005) - Phase 2 trial of Oral Tenofovir use as a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process. The Policy Projects, The Futures Group International 2001- 2002 Consultancy Co-authored a policy paper titled Access to Drugs for HIV/AIDS and Related Opportunistic Infections in Nigeria. Medecins sans Frontieres Holland (Doctors without Borders) 2000- 2002 Coalition of Civil Society Groups on Access to Essential Medicines 2000-2002 P